Semaglutide shows promise in reducing cravings for alcohol, heavy drinking, finds study Dr. Kamal Kant Kohli14 Feb 2025 8:15 AM ISTThe blockbuster drug semaglutide, better known as Ozempic for diabetes and Wegovy for obesity, could also help people cut down on their alcohol...
FDA approves Semaglutide for renal protection among diabetes patients with CKD Dr. Kamal Kant Kohli30 Jan 2025 9:00 AM ISTNovo Nordisk has announced that the Food and Drug Administration (FDA) has approved semaglutide (Ozempic) to reduce the risk of worsening kidney...
Novo Nordisk Ozempic get USFDA nod for reduction of kidney disease worsening risk, cardiovascular death in adults with type 2 diabetes, chronic kidney disease Ruchika Sharma29 Jan 2025 1:30 PM ISTPlainsboro: Novo Nordisk has announced that the U.S. Food and Drug Administration (FDA) has approved Ozempic to reduce the risk of kidney disease...
Which are High-impact clinical trials that may generate promising results for improving kidney health? Dr Kartikeya Kohli1 Nov 2024 8:00 PM ISTThe results of numerous high-impact phase 3 clinical trials that could affect kidney-related medical care will be presented in-person at ASN Kidney...
Semaglutide may reduce risk of Alzheimer's disease in diabetes patients, suggests study Dr. Kamal Kant Kohli25 Oct 2024 8:00 PM ISTResearchers at the Case Western Reserve School of Medicine have found that semaglutide, a popular diabetes and weight-loss drug, may lower the risk of...
Glucagon-like peptide-1 receptor agonists may be new treatment for opioid and alcohol use disorder, finds study Dr. Kamal Kant Kohli19 Oct 2024 9:00 AM ISTOzempic is one of several medications, called glucagon-like peptide-1 receptor agonists or GLP-1 RAs, that are prescribed to treat diabetes, obesity,...
Natco Pharma partner Mylan settles patent litigation with Novo Nordisk over generic Ozempic in US Ruchika Sharma7 Oct 2024 12:30 PM ISTHyderabad: NATCO Pharma Limited has announced that its partner Mylan Pharmaceuticals Inc. and Novo Nordisk have reached a settlement of the U.S....
Semaglutide associated with lower opioid overdoses in people OUD and type 2 diabetes: JAMA Dr. Kamal Kant Kohli27 Sept 2024 9:00 AM ISTSince being deemed a public health emergency in 2017, opioids are responsible for 72% of drug overdose deaths in the United States, according to the...
JAMA Study finds No link between GLP-1 analogues and suicide Dr. Kamal Kant Kohli5 Sept 2024 9:00 AM ISTThere has been concern that common diabetes drugs could increase the risk of suicide and self-harm. In a new study, led by researchers at Karolinska...
Combining Two Diabetes Drugs Helps Promote Weight Loss and Blood Sugar Control, suggests study Dr. Kamal Kant Kohli2 Sept 2024 7:00 AM ISTNew research finds a combination of drugs improves weight loss, glucose control and insulin resistance better than either drug alone. Using two...
Medical Bulletin 15/ July/ 2024 Anshika Mishra15 July 2024 3:00 PM ISTHere are the top medical news for the day:Ozempic Use Linked to Reduced Dementia Risk, Nicotine Consumption: Study A widely used diabetes medication,...
Ozempic Use Linked to Reduced Dementia Risk, Nicotine Consumption: Study Anshika Mishra15 July 2024 8:00 AM ISTA widely used diabetes medication, Ozempic (semaglutide), may be associated with a reduced risk of cognitive issues, according to an observational...
